Bioniche and Grunenthal Sign Agreement for Distribution of Suplasyn

Bioniche Life Sciences, a research-based, technology-driven human and animal health biopharmaceutical company, announced that its specialty pharmaceutical business unit, Bioniche Pharma Group Limited, has signed an exclusive agreement with The Grunenthal Group for distribution of Bioniche's proprietary product, Suplasyn in the Czech Republic, the Slovak Republic, Poland, and Russia.

()a href="http://www.newswire.ca/en/releases/archive/June2005/01/c5735.html" target="_blank">Canada NewsWire Group